Utility of Peak Creatine Kinase-MB Measurements in Predicting Myocardial Infarct Size, Left Ventricular Dysfunction and Outcome After First Anterior Wall Acute Myocardial Infarction (From the INFUSE-AMI Trial)

Infarct size after ST-segment elevation myocardial infarction (STEMI) is associated with long-term clinical outcomes. However, there is insufficient information correlating CK-MB or troponin levels to infarct size and infarct location in first–time occurrence STEMI. We, therefore, assessed the utility of CK-MB measurements after primary percutaneous coronary intervention (PCI) of a first anterior STEMI utilizing bivalirudin anticoagulation in patients who were randomized to intralesion abciximab vs.

Source: The American Journal of Cardiology - December 17, 2014 Category: Cardiology Authors: Tomotaka Dohi, Akiko Maehara, Sorin J. Brener, Philippe Généreux, Anthony H. Gershlick, Roxana Mehran, C. Michael Gibson, Gary S. Mintz, Gregg W. Stone Source Type: research